Leith Wheeler Investment Counsel’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$273K Buy
1,745
+300
+21% +$45K 0.02% 82
2026
Q1
$221K Buy
+1,445
New +$222K 0.02% 83

Other funds holding NVS

Leith Wheeler Investment Counsel's NVS Position: Q2 2026 in Review

Leith Wheeler Investment Counsel increased its Novartis (NVS) stake by 21% in Q2 2026, buying an estimated $45K and bringing the position to 1,745 shares worth $273K. The position accounts for 0.02% of the portfolio, ranked #82.

Leith Wheeler Investment Counsel first reported a position in NVS in Q1 2026 and has held it in 2 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Leith Wheeler Investment Counsel held 1,745 shares of Novartis worth $273K as of Q2 2026.
  • Leith Wheeler Investment Counsel bought 300 Novartis shares in Q2 2026, an estimated $45K.
  • Novartis made up 0.02% of Leith Wheeler Investment Counsel's portfolio in Q2 2026, its #82 holding.
  • Leith Wheeler Investment Counsel first reported a position in Novartis in Q1 2026 and has held it in 2 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Leith Wheeler Investment Counsel's 13F filing for Q2 2026, filed 5 Aug 2026.